Lexaria Bioscience Corp.
Nasdaq · Healthcare · Pharmaceutical Preparations · Kelowna, British Columbia, Canada
LEXX chart
What traders are saying about $LEXX
Latest postsLexaria Bioscience Corp. news
- LEXX: New Pharmaceutical Agreement
Yahoo Finance ·
- Lexaria Bioscience | 8-K: Current report
Moomoo ·
- Lexaria Bioscience Corp. (LEXX) Seasonal returns chart
Yahoo Finance UK ·
- Lexaria Bioscience Corp. (LEXXW) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
Yahoo Finance ·
- A drugmaker agreed to supply proprietary molecules for tests of Lexaria’s oral medicine-delivery technology.
Stock Titan ·
- Lexaria signs third pharma deal to test Dehydra...
Pluang ·
- Lexaria Celebrates its 70th Patent Award
Yahoo Finance ·
- Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
Yahoo Finance ·
- Lexaria Announces Results from Animal Study GLP-1-A26-1
Yahoo Finance ·
- GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
Yahoo Finance ·
- Lexaria Updates Financial Position
Yahoo Finance ·
Lexaria Bioscience Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $464,278 | $226,208 | $255,397 |
| Net income | -$11.9M | -$5.8M | -$6.7M | -$7.3M |
| Diluted EPS | $-0.66 | $-0.47 | $-1.01 | – |
| Total assets (year end) | $6.1M | $9.8M | $3.6M | $6.2M |
| Cash and equivalents (year end) | $4.3M | – | – | $4.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lexaria Bioscience Corp.
- Ticker
- LEXX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Kelowna, British Columbia, Canada
- Incorporated in
- NV
- Fiscal year end
- August 31
- SEC CIK
- 1348362
- Former names
- Lexaria Corp., LEXARIA CORP.
Frequently asked questions
What exchange is Lexaria Bioscience Corp. listed on?
Lexaria Bioscience Corp. trades on the Nasdaq under the ticker symbol LEXX.
What industry is Lexaria Bioscience Corp. in?
Lexaria Bioscience Corp. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lexaria Bioscience Corp. headquartered?
Lexaria Bioscience Corp.'s business address on file with the SEC is in Kelowna, British Columbia, Canada.
When does Lexaria Bioscience Corp.'s fiscal year end?
Lexaria Bioscience Corp.'s fiscal year ends on August 31.
How much revenue did Lexaria Bioscience Corp. report?
Lexaria Bioscience Corp. reported $464,278 in revenue for calendar year 2024, according to its SEC filings.